Targeting the coagulation factor fibrinogen for arthritis therapy

Area of Science:

• Biochemistry
• Immunology
• Rheumatology

Background:

• Fibrinogen is essential for blood clot formation and hemostasis.
• Fibrin deposition is prevalent in inflammatory diseases such as rheumatoid arthritis.
• Emerging evidence suggests fibrin actively contributes to inflammatory disease pathogenesis.

Purpose of the Study:

• To investigate the role of fibrinogen-integrin interactions in inflammatory disease.
• To explore targeting fibrinogen as an anti-inflammatory strategy.

Main Methods:

• Investigated fibrinogen's role as a ligand for cell-surface receptors.
• Focused on the interaction between fibrinogen and the leukocyte integrin αMβ2.
• Assessed the impact of blocking fibrinogen-αMβ2 interactions on inflammatory disease progression.

Main Results:

• Fibrinogen binding to leukocyte integrin αMβ2 is a key driver of local inflammation.
• Eliminating fibrinogen-αMβ2 interactions significantly limits inflammatory disease progression, including arthritis.
• These interactions can be targeted without compromising fibrinogen's essential hemostatic functions.

Conclusions:

• Fibrinogen actively promotes inflammation through integrin interactions.
• Targeting fibrinogen-integrin pathways offers a novel therapeutic strategy for inflammatory diseases.
• This approach preserves hemostasis while mitigating inflammation.